IP Library Granted Patent US 9,744,074
Granted Patent B2
US 9,744,074 · App. 14/847,580 · Granted Aug 29, 2017

Combination treatments

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,744,074
App. No.
14/847,580
Granted
Aug 29, 2017
Kind
B2
Abstract

A method of treating a subject in need thereof, is carried out by (a) administering said subject a therapeutic intervention (e.g., an active agent) in a treatment effective amount; and concurrently (b) administering said subject caloric vestibular stimulation in a treatment effective amount, said caloric vestibular stimulation administered so as to enhance the efficacy of said active agent. In some embodiments, the caloric vestibular stimulation is administered as an actively controlled time varying waveform.

Claims (10)

1. A method of treating a subject afflicted with headache and in need of treatment thereof, comprising:

(a) administering said subject an active agent in a treatment effective amount; and concurrently

(b) administering said subject caloric vestibular stimulation in a treatment effective amount, said caloric vestibular stimulation administered so as to enhance the efficacy of said active agent, wherein said caloric vestibular stimulation is administered as an actively controlled time varying waveform and the subject is afflicted with headache, and said active agent comprises a headache medication or an analgesic for treating headache.

2. The method of claim 1 , wherein said active agent is administered orally.

3. The method of claim 1 , wherein said headache is chronic migraine headache.

4. The method of claim 1 , wherein said headache is episodic migraine headache.

5. The method of claim 1 , wherein said caloric vestibular stimulation is administered for a time sufficient to induce nystagmus over a period of at least five minutes.

6. The method of claim 1 , wherein said headache is a tension-type headache.

7. The method of claim 1 , wherein said headache is a trigeminal autonomic cephalagias headache.

8. The method of claim 1 , wherein said headache is a vestibular migraine headache.

Assignments (1)
CHANGE OF NAME Recorded Jul 21, 2023
From: SCION NEUROSTIM, LLC
To: SCION NEUROSTIM, INC.
Reel/Frame 064360/0875 →